The July FDA Peptide Vote: What It Actually Means for Patients and Compounding Pharmacies
On July 23–24, the FDA's Pharmacy Compounding Advisory Committee will review seven popular peptides. We break down the agenda, the end of the Category 1 vs. Category 2 era, and the realistic odds for each substance.
July 17, 20265 min read
Read Article ›